Profile
CVM VRTX REGN ALNY SGEN ARGX
Company Name CEL-SCI Corporation Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $52.51M $101.51B $57.98B $56.69B $43.15B $39.02B
Employees 0.04K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Geert R. Kersten Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
CVM VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 3 4 1 3 4
Quant Rating Sell Neutral Buy Strong Sell Neutral Buy
Trading
CVM VRTX REGN ALNY SGEN ARGX
Last Close $8.35 $395.92 $561.55 $432.52 $228.74 $646.6
High 52 $9.45 $516.74 $1201.76 $438.93 $228.74 $690.32
Low 52 $0.19 $366.54 $482.92 $224.58 $228.74 $514.23
Price vs. 52 Week High -11.64 % -23.38 % -53.27 % -1.46 % 0 % -6.33 %
Price vs. 52 Week Low 4294.74 % 8.02 % 16.28 % 92.59 % 0 % 25.74 %
Total Return
CVM VRTX REGN ALNY SGEN ARGX
1 Month Return 129.4 % -16.18 % -1.58 % 36.98 % 0 % 15.2 %
3 Month Return 3361.86 % -5.99 % -1.72 % 61.66 % 0 % 21.48 %
6 Month Return 1902.4 % -13.74 % -16.63 % 68.66 % 0 % 1.12 %
9 Month Return 1390.81 % -18.19 % -28.24 % 67.7 % 0 % 8.66 %
YTD Return 1988.02 % -1.68 % -21.17 % 83.81 % 0 % 5.14 %
1 Year Return 626.09 % -16.02 % -51.46 % 64.53 % 0 % 23.78 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CVM VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -235.01 % 11.09 % 4.37 % -0.43 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 4.18 % - - -
Growth
CVM VRTX REGN ALNY SGEN ARGX
Asset Growth -11.58 % -0.87 % 14.15 % 10.71 % -1.21 % 36.55 %
Gross Profit Growth -0.27 % 10.25 % 8.23 % 26.81 % 22.93 % 77.08 %
Revenue Growth - 11.66 % 8.27 % 22.97 % 24.65 % 78.6 %
Revenue 3 Year - 45.6 % -13.44 % 147.1 % 91.56 % 275.84 %
Revenue 5 Year -100 % 163.93 % 82.78 % 775.72 % 215.48 % 1701.04 %
Revenue 10 Year -100 % 1632.15 % 429.43 % 2487.4 % 494.04 % 5950.81 %
EBIT Growth 16.96 % -93.69 % 13.17 % 24.59 % - 128.87 %
Net Income Growth 16.82 % -114.8 % 11.61 % 36.82 % 9.51 % 382.34 %
Net Income 3 Yeari Growth Per Share 53.18 % -122.89 % -46.47 % 69.73 % -763.59 % 274.39 %
Net Income 5 Yeari Growth Per Share 37.74 % -145.38 % 111.07 % 73.13 % -276.93 % 396.61 %
Net Income 10 Yeari Growth Per Share 95.45 % 33.84 % 1232.49 % 55.09 % -624.16 % 938.02 %
Operating Income Growth 16.28 % -106.08 % -1.39 % 37.31 % 10.13 % 94.91 %
Operating Cash Flow Growth (CFG) 17.67 % -113.93 % -3.78 % -107.98 % 9.07 % 80.31 %
Operating 3 Year CFG 31.76 % -118.65 % -38.85 % 98.8 % -147.99 % 88.36 %
Operating 5 Year CFG 34.18 % -131.3 % 84.11 % 97.44 % -195.86 % -135.21 %
Operating 10 Year CFG 96.21 % 12.43 % 517.51 % 97.08 % -2622.09 % -64 %
EPS Growth 38.36 % -114.8 % 10.39 % 38.64 % 10.81 % 369.77 %
EPS Diluted Growth 38.36 % -114.97 % 10.27 % 38.64 % 10.81 % 347.67 %
Book Value Per Share -27.41 % -6.59 % 11.76 % 129.75 % -9.83 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -84.49 % 62.6 % 53.21 % -89.42 % 33.72 % 85.14 %
Share Holder 5 Year Equity Growth Per Share 43.13 % 168.85 % 167.88 % -96.01 % 220.81 % 200.53 %
Share Holder 10 Year Equity Growth Per Share -94.3 % 1265.7 % 1113.59 % -95.83 % 691.19 % 1039.11 %
Dividend Per Share Growth - - - - - -
Dividend 3 Year Growth Per Share - - - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - - - - - -
Debt Growth -14.37 % 116.42 % 0.06 % 2.27 % -23.28 % 95.27 %
Free Cash Flow Growth 18.58 % -124.1 % -0.08 % -201.54 % 3.67 % 67.46 %
Updated On 30 Sep 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2022 31 Dec 2024
Profitability
CVM VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM - 86.11 % 84.62 % 83.64 % 79.1 % 65.32 %
Return on Assets TTM -91.89 % 15.13 % 11.67 % -6.99 % -16.61 % 15.06 %
Return on Equity TTM -197.2 % 22.14 % 15.11 % -274.21 % -20.8 % 18.96 %
Return on Capital Employed TTM -120.71 % 19.72 % 11.15 % -5.52 % -21.46 % 5.04 %
Net Income Per EBT TTM 100 % 83.16 % 91.46 % 84.06 % 101.33 % 237.3 %
EBT Per Ebit TTM 101.8 % 111.48 % 126.59 % 210.66 % 98.26 % 147.38 %
EBIT Per Revenue TTM - 34.36 % 27.09 % -7.32 % -31.24 % 13.47 %
Cash Flow To Debt Ratio TTM -170.02 % 251.83 % 175.35 % -1.2 % -1043.73 % -175.92 %
Receivables Turnover TTM - 6.03 2.53 4.34 3.91 1.91
Payables Turnover TTM 1.16 0.43 3.02 3.93 1.97 0.88
Inventory Turnover TTM - 1.06 0.68 5.62 0.96 2.21
Fixed Asset Turnover TTM - 431.08 % 293.64 % 355.68 % 665.41 % 5009.77 %
Asset Turnover TTM - 47.51 % 37.19 % 53.92 % 53.41 % 31.97 %
Operating Cash Flow Per Share TTM -6353.9 14.98 45.13 -0.12 -2.46 -1.07
Free Cash Flow Per Share TTM -6368.52 13.63 36.58 -0.4 -2.88 -1.09
Cash Per Share TTM 68286.78 % 3036 % 7107.14 % 2203.63 % 939.52 % 5536.58 %
Operating Cash Flow Sales Ratio TTM - 33.68 % 33.37 % -0.63 % -23.12 % -3.31 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.23 % 90.99 % 81.05 % 335.21 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -170.02 % 251.83 % 175.35 % -1.2 % -1043.73 % -175.92 %
Price To Free Cash Flows Ratio TTM -2.93 29.01 15.08 -1088.43 -81.26 -509.15
Price To Operating Cash Flows Ratio TTM - 26.42 12.33 -3609.46 -93.1 -603.58
Price Cash Flow Ratio TTM - 26.42 12.33 -3609.46 -93.1 -603.58
Income Statement (TTM)
CVM VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $-0B $9.49B $11.75B $1.92B $1.55B $1.96B
Gross Profit Ratio 0% 86.11% 82.74% 85.62% 79.1% 89.62%
EBITDA $-0.02B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.03B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -13.5 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
CVM VRTX REGN ALNY SGEN ARGX
Long Term Debt $0.01B $1.66B $2.7B $1.25B $0.04B $0.03B
Total Liabilities $0.01B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.01B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0.01B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.03B $22.53B $37.76B $4.24B $3.67B $6.2B
Cash Flow Statement (TTM)
CVM VRTX REGN ALNY SGEN ARGX
Net Income $-0.03B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 42.055
AARD Aardvark Therapeutics, Inc. Common Stock 11.47
ABCL AbCellera Biologics Inc. 4.625
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 7.12
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.2801
ABPWW 0.0301
ABSI Absci Corporation 3.035
ABUS Arbutus Biopharma Corporation 3.385
ABVC ABVC BioPharma, Inc. 3.03
ABVX Abivax SA American Depositary Shares 69.31
ACAD ACADIA Pharmaceuticals Inc. 24.59
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6515
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.46
ACIU AC Immune SA 2.12
ETFs With Exposure to CVM
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00002 317.03
IBB iShares Biotechnology ETF 0.01 137.065
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 140.825
VXF Vanguard Extended Market Index Fund 0.00006 200.385
IWC iShares Micro-Cap ETF 0.00106 136.735
BTEC Principal Healthcare Innovators ETF 0.03 39.49
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 218.805
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 108.02
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 108
VQNPX Vanguard Growth and Income Fund 0 69.38
VGIAX Vanguard Quantitative Funds - Vanguard Growth and Income Fund 0 113.22
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 51.36
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 51.35
VBINX Vanguard Balanced Index Fund Investor Shares 0 51.35
VALT ETFMG Sit Ultra Short ETF 0.12 48.52
GERM ETFMG Treatments, Testing and Advancements ETF 0.16 19.1577
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 0.19 1.75
VTSAX Vanguard Total Stock Market Index Fund 0 154.61
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00006 154.23
VITSX Vanguard Total Stock Market Index Fund 0 154.63
DFSU Dimensional US Sustainability Core 1 ETF 0.000007 41.05
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000085398 109.39
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00006 154.24
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
VEMPX Vanguard Extended Market Index InstlPlus 0.00006 380.61
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00002 290.08
Unlock